Trade Alibaba Health Information Technology Limited - 0241 CFD
What is Alibaba Health (241)?
Alibaba Health Information Technology Limited is a Chinese company specializing in healthcare technology and services. It operates as a subsidiary within the broader Alibaba Group ecosystem, focusing on integrating digital technologies with healthcare services. The company provides a range of products and services including online pharmaceutical sales, health information management, and medical data analytics. It aims to enhance the accessibility and efficiency of healthcare through digital innovation, leveraging big data and cloud computing to support medical institutions, pharmaceutical companies, and consumers. Alibaba Health also engages in the development of healthcare platforms that facilitate drug traceability, electronic prescriptions, and health management solutions. Its operations contribute to the modernization of healthcare infrastructure in China by promoting the use of technology in medical supply chains and patient care. The company plays a role in the intersection of technology and healthcare, reflecting broader trends in digital health transformation and the integration of e-commerce with medical services.
Alibaba Health Stock Price Today: Live Overview
The price today is shaped by live market dynamics, with Alibaba Health at HK$4.72. It has moved within a daily range of HK$4.63 to HK$4.76, changing by -1.4644%.
FAQ: Alibaba Health (241)
What is the current price of 241 stock?
The current price stands at HK$4.72.
Does 241 pay dividends?
The company pays dividends via cash distributions (if applicable).
Does 241 have a formal corporate presence or regional headquarters in the UAE?
Alibaba Health does not have an official regional office or subsidiary in the UAE and relies on partners and distributors for operations.
What is 241 best known for?
Alibaba Health is most famous for its digital health services and online pharmaceutical platform.
What assets are typically shown together with 241?
Commonly shown alongside 241: State Street SPDR S&P 400 Mid Cap Value ETF, Mutares SE & Co KgaA, Citius Pharmaceuticals, Inc.
Latest shares articles



